98%
921
2 minutes
20
Right ventricular dysfunction (RVD) predicts poor survival in chronic heart failure (HF). Sex differences in RVD have been suggested but are still unraveled. We studied the influence of sex in the prognostic impact of RVD in chronic HF. We retrospectively analyzed adult ambulatory chronic HF patients with left ventricular systolic dysfunction (LVSD) followed from January 2012 to December 2020. Patients with no data on right ventricular function were excluded. Primary outcome: all-cause mortality; follow-up: January 2023. A Cox-regression analysis was used to determine the prognostic impact of RVD, adjustment for confounders was performed. Interaction between sex and RVD was tested. The analysis was stratified according to sex. We studied 1,152 patients, 65% male, mean age 71 years. RVD coexisted in 192 (17%). Patients with RVD were younger, more often presented atrial fibrillation and nonischemic HF, they had more severe LVSD, were more symptomatic, and presented higher BNP levels. During a median 44-month follow-up, 618 (54%) patients died. Patients with RVD presented higher all-cause mortality: multivariate-adjusted HR = 1.86 (1.26 to 2.76). When the analysis was stratified according to sex this negative prognostic impact was only present in females: multivariate-adjusted HR = 1.56 (1.02 to 2.39). The present of RVD was not prognostic associated in men. There was interaction between sex and RVD, p = 0.03. In conclusion, RVD appears to be associated with ominous outcome only in female patients: women with systolic HF with RVD presented a 56% higher risk of dying. In male HF patients, RVD showed no prognostic implications. Sex seems to influence the prognostic impact of RDV in chronic HF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjcard.2025.03.029 | DOI Listing |
JMIR Hum Factors
September 2025
College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.
Background: The rapid advancement of next-generation sequencing has significantly expanded the landscape of precision medicine. However, health care professionals face increasing challenges in keeping pace with the growing body of oncological knowledge and integrating it effectively into clinical workflows. Precision oncology decision support (PODS) tools aim to assist clinicians in navigating this complexity, yet their current functionalities only partially address clinical needs.
View Article and Find Full Text PDFAnn Am Thorac Soc
September 2025
University of California Los Angeles David Geffen School of Medicine, Medicine, Los Angeles, California, United States.
Rationale: Inflammation is central to chronic obstructive pulmonary disease (COPD) pathogenesis but incompletely represented in COPD prognostic models. Neutrophil to lymphocyte ratio (NLR) is a readily available inflammatory biomarker.
Objectives: To explore the associations of NLR with smoking status, clinical features of COPD, and future adverse outcomes.
J Thorac Oncol
July 2025
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Introduction: TNM staging systems create prognostic categories by anatomic extent of disease. Whether therapeutically important molecular alterations in NSCLC augment the prognostic information of TNM staging is unclear. To study this, we analyzed molecular data from the ninth edition of the lung cancer staging system.
View Article and Find Full Text PDFJ Thorac Oncol
August 2025
Department of Radiation Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
Introduction: Cigarette smoking negatively affects lung cancer prognosis. Incorporating smoking history into stage-stratified survival analyses may improve prognostication.
Methods: Using the International Association for the Study of Lung Cancer ninth edition NSCLC database, we evaluated the association between smoking status at diagnosis and overall survival (OS) using Kaplan-Meier plots and multivariate Cox proportional hazard regression models adjusted for age, region, sex, histologic type, performance status, and TNM stage.
Am J Hematol
September 2025
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) is a life-threatening hyperinflammatory syndrome, and hierarchical management based on a prognostic model is important. The endothelial activation and stress index (EASIX) score has demonstrated prognostic utility in recipients of allogeneic stem cell transplantation and chimeric antigen receptor (CAR) T-cell therapy. However, its role in LA-HLH remains unestablished.
View Article and Find Full Text PDF